REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 186 filers reported holding REGENXBIO INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,940 | -5.6% | 2,305 | +14.7% | 0.00% | – |
| Q2 2023 | $40,180 | -50.1% | 2,010 | -52.8% | 0.00% | – |
| Q1 2023 | $80,552 | -88.8% | 4,260 | -86.6% | 0.00% | – |
| Q4 2022 | $720,952 | -13.9% | 31,788 | +0.4% | 0.00% | – |
| Q3 2022 | $837,000 | +7.3% | 31,663 | +0.2% | 0.00% | – |
| Q2 2022 | $780,000 | +114.9% | 31,592 | +189.1% | 0.00% | – |
| Q1 2022 | $363,000 | +205.0% | 10,929 | +199.3% | 0.00% | – |
| Q4 2021 | $119,000 | -95.0% | 3,652 | -93.6% | 0.00% | – |
| Q3 2021 | $2,374,000 | +303.7% | 56,632 | +274.1% | 0.00% | – |
| Q2 2021 | $588,000 | +14.0% | 15,140 | +0.1% | 0.00% | – |
| Q1 2021 | $516,000 | -24.7% | 15,131 | +0.2% | 0.00% | – |
| Q4 2020 | $685,000 | +31.7% | 15,108 | -20.1% | 0.00% | – |
| Q3 2020 | $520,000 | -88.2% | 18,908 | -84.2% | 0.00% | – |
| Q2 2020 | $4,413,000 | -65.5% | 119,808 | -69.6% | 0.00% | -100.0% |
| Q1 2020 | $12,781,000 | -27.1% | 394,708 | -7.8% | 0.00% | 0.0% |
| Q4 2019 | $17,540,000 | +10.7% | 428,108 | -3.8% | 0.00% | 0.0% |
| Q3 2019 | $15,842,000 | -43.6% | 445,008 | -18.6% | 0.00% | -33.3% |
| Q2 2019 | $28,094,000 | -43.2% | 546,894 | -36.7% | 0.00% | -50.0% |
| Q1 2019 | $49,475,000 | +25.3% | 863,294 | -8.3% | 0.01% | +20.0% |
| Q4 2018 | $39,472,000 | -52.2% | 940,942 | -14.1% | 0.01% | -44.4% |
| Q3 2018 | $82,657,000 | -29.1% | 1,094,794 | -32.6% | 0.01% | -30.8% |
| Q2 2018 | $116,507,000 | +93.8% | 1,623,794 | -19.4% | 0.01% | +85.7% |
| Q1 2018 | $60,103,000 | -13.6% | 2,013,494 | -3.7% | 0.01% | -12.5% |
| Q4 2017 | $69,546,000 | -5.3% | 2,091,594 | -6.1% | 0.01% | -11.1% |
| Q3 2017 | $73,403,000 | +63.5% | 2,227,694 | -2.0% | 0.01% | +50.0% |
| Q2 2017 | $44,882,000 | +2.2% | 2,272,494 | -0.1% | 0.01% | 0.0% |
| Q1 2017 | $43,900,000 | +3.5% | 2,274,594 | -0.5% | 0.01% | 0.0% |
| Q4 2016 | $42,401,000 | +251.9% | 2,285,794 | +165.7% | 0.01% | +200.0% |
| Q3 2016 | $12,050,000 | -21.7% | 860,130 | -55.3% | 0.00% | 0.0% |
| Q2 2016 | $15,381,000 | -53.7% | 1,922,582 | -37.5% | 0.00% | -60.0% |
| Q1 2016 | $33,232,000 | -39.5% | 3,077,061 | -6.9% | 0.01% | -28.6% |
| Q4 2015 | $54,894,000 | -19.0% | 3,306,862 | +7.6% | 0.01% | -30.0% |
| Q3 2015 | $67,733,000 | – | 3,074,566 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |